Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling

Date of publication: 11-01-2018
Missed doses of Clopidogrel increases the risk of heart attack and stroke which can be life threatening. Źródło: https://www.fda.gov